Breakwater Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24K Buy
259
+44
+20% +$1.15K ﹤0.01% 256
2026
Q1
$6.04K Hold
215
﹤0.01% 255
2025
Q4
$5.35K Hold
215
﹤0.01% 257
2025
Q3
$5.48K Buy
215
+21
+11% +$518 ﹤0.01% 254
2025
Q2
$4.7K Hold
194
﹤0.01% 256
2025
Q1
$4.92K Hold
194
﹤0.01% 254
2024
Q4
$5.15K Hold
194
﹤0.01% 246
2024
Q3
$5.62K Hold
194
﹤0.01% 243
2024
Q2
$5.43K Hold
194
﹤0.01% 255
2024
Q1
$5.38K Buy
+194
New +$5.38K ﹤0.01% 249

Other funds holding PFE

Breakwater Investment Management's PFE Position: Q2 2026 in Review

Breakwater Investment Management increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $1.15K and bringing the position to 259 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Breakwater Investment Management first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Breakwater Investment Management held 259 shares of Pfizer worth $6.24K as of Q2 2026.
  • Breakwater Investment Management bought 44 Pfizer shares in Q2 2026, an estimated $1.15K.
  • Pfizer made up ﹤0.01% of Breakwater Investment Management's portfolio in Q2 2026, its #256 holding.
  • Breakwater Investment Management first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Breakwater Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.